Cerity Partners’s ACELYRIN SLRN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLRN
Cerity Partners's SLRN Position: Q2 2025 in Review
Cerity Partners sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 10,419 shares — an estimated $25.7K sold.
Cerity Partners first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $25.7K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.
- Cerity Partners reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
- Cerity Partners sold 10,419 ACELYRIN shares in Q2 2025, an estimated $25.7K.
- Cerity Partners first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
- Cerity Partners's ACELYRIN position peaked at $25.7K in Q1 2025.
- 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.
Based on Cerity Partners's 13F filing for Q2 2025, filed 13 Aug 2025.